A detailed history of Callan Family Office, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Callan Family Office, LLC holds 13,271 shares of ZTS stock, worth $1.58 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,271
Previous 15,717 15.56%
Holding current value
$1.58 Million
Previous $2.45 Billion 20.78%
% of portfolio
0.06%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$141.13 - $159.19 $345,203 - $389,378
-2,446 Reduced 15.56%
13,271 $1.94 Billion
Q2 2025

Jul 24, 2025

BUY
$144.41 - $170.3 $1.32 Million - $1.56 Million
9,170 Added 140.06%
15,717 $2.45 Billion
Q1 2025

May 12, 2025

SELL
$156.48 - $175.67 $57,897 - $64,997
-370 Reduced 5.35%
6,547 $1.08 Billion
Q4 2024

Feb 06, 2025

BUY
$162.24 - $194.42 $1.12 Million - $1.34 Million
6,917 New
6,917 $1.13 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $55.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.